Autus Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $12.3M | Sell |
75,934
-1,896
| -2% | -$291K | 2.21% | 10 |
|
|
2022
Q3 | $10.4M | Sell |
77,830
-255
| -0.3% | -$36.6K | 2% | 12 |
|
|
2022
Q2 | $12M | Sell |
78,085
-1,440
| -2% | -$220K | 2.13% | 11 |
|
|
2022
Q1 | $12.9M | Sell |
79,525
-19,413
| -20% | -$2.82M | 1.93% | 12 |
|
|
2021
Q4 | $13.4M | Buy |
98,938
+2,370
| +2% | +$280K | 1.35% | 24 |
|
|
2021
Q3 | $10.4M | Buy |
96,568
+2,516
| +3% | +$287K | 1.14% | 39 |
|
|
2021
Q2 | $10.6M | Buy |
94,052
+545
| +0.6% | +$61.4K | 1.16% | 34 |
|
|
2021
Q1 | $10.1M | Buy |
93,507
+2,335
| +3% | +$250K | 1.19% | 33 |
|
|
2020
Q4 | $9.77M | Sell |
91,172
-5,540
| -6% | -$532K | 1.26% | 30 |
|
|
2020
Q3 | $8.47M | Buy |
96,712
+1,562
| +2% | +$147K | 1.12% | 37 |
|
|
2020
Q2 | $9.34M | Buy |
95,150
+931
| +1% | +$82K | 1.36% | 28 |
|
|
2020
Q1 | $7.18M | Buy |
94,219
+4,547
| +5% | +$387K | 1.26% | 33 |
|
|
2019
Q4 | $7.94M | Buy |
89,672
+426
| +0.5% | +$35.4K | 1.15% | 36 |
|
|
2019
Q3 | $6.76M | Buy |
89,246
+3,948
| +5% | +$271K | 1.06% | 41 |
|
|
2019
Q2 | $6.2M | Buy |
85,298
+7,390
| +9% | +$581K | 0.98% | 44 |
|
|
2019
Q1 | $6.28M | Buy |
77,908
+63,223
| +431% | +$5.17M | 1.04% | 40 |
|
|
2018
Q4 | $1.35M | Hold |
14,685
| – | – | 0.26% | 76 |
|
|
2018
Q3 | $1.39M | Sell |
14,685
-75
| -0.5% | -$7.11K | 0.23% | 78 |
|
|
2018
Q2 | $1.37M | Buy |
14,760
+635
| +4% | +$62K | 0.24% | 77 |
|
|
2018
Q1 | $1.34M | Sell |
14,125
-950
| -6% | -$104K | 0.24% | 78 |
|
|
2017
Q4 | $1.46M | Sell |
15,075
-100
| -0.7% | -$9.43K | 0.27% | 77 |
|
|
2017
Q3 | $1.35M | Sell |
15,175
-100
| -0.7% | -$7.61K | 0.26% | 76 |
|
|
2017
Q2 | $1.11M | Sell |
15,275
-415
| -3% | -$27.9K | 0.22% | 81 |
|
|
2017
Q1 | $1.02M | Sell |
15,690
-173
| -1% | -$10.9K | 0.21% | 84 |
|
|
2016
Q4 | $993K | Buy |
15,863
+111
| +0.7% | +$6.78K | 0.22% | 86 |
|
|
2016
Q3 | $993K | Sell |
15,752
-98
| -0.6% | -$6.34K | 0.22% | 86 |
|
|
2016
Q2 | $981K | Sell |
15,850
-149
| -0.9% | -$9.08K | 0.22% | 88 |
|
|
2016
Q1 | $914K | Sell |
15,999
-395
| -2% | -$22K | 0.22% | 92 |
|
|
2015
Q4 | $971K | Buy |
16,394
+469
| +3% | +$27K | 0.25% | 90 |
|
|
2015
Q3 | $866K | Sell |
15,925
-100
| -0.6% | -$6.51K | 0.26% | 77 |
|
|
2015
Q2 | $1.08M | Buy |
16,025
+100
| +0.6% | +$6.53K | 0.3% | 74 |
|
|
2015
Q1 | $932K | Buy |
+15,925
| New | +$962K | 0.26% | 78 |
|
Other funds holding ABBV
AWA
Autus Asset Management's ABBV Position: Q4 2022 in Review
Autus Asset Management reduced its AbbVie (ABBV) stake by 2.4% in Q4 2022, selling an estimated $291K and leaving 75,934 shares worth $12.3M. The position accounts for 2.21% of the portfolio, ranked #10.
Autus Asset Management first reported a position in ABBV in Q1 2015 and has held it in 32 quarters since. The position peaked at $13.4M in Q4 2021. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.
- Autus Asset Management held 75,934 shares of AbbVie worth $12.3M as of Q4 2022.
- Autus Asset Management sold 1,896 AbbVie shares in Q4 2022, an estimated $291K.
- AbbVie made up 2.21% of Autus Asset Management's portfolio in Q4 2022, its #10 holding.
- Autus Asset Management first reported a position in AbbVie in Q1 2015 and has held it in 32 quarters since.
- Autus Asset Management's AbbVie position peaked at $13.4M in Q4 2021.
- 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.
Based on Autus Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.